Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13400488 | 0.84 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2HTTPOLBMAPT | |
| SCHEMBL13714597 | 0.77 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2HTTPOLBMAPT | |
| SCHEMBL13133187 | 0.76 | SMN1; SMN2 (0.32) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL12919556 | 0.76 | SMN1; SMN2 (0.53) | ALDH1A1SMN1; SMN2HTTTSHRKMT2A | |
| SCHEMBL4757871 | 0.76 | SMN1; SMN2 (0.46) | ALDH1A1SMN1; SMN2HTTPOLBMAPT | |
| SCHEMBL13534109 | 0.74 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2POLBKMT2A | |
| SCHEMBL17249590 | 0.74 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2POLBKMT2A | |
| SCHEMBL13400486 | 0.74 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2HTTPOLBKMT2A | |
| SCHEMBL10361486 | 0.74 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2HTTCYP3A4TSHR | |
| SCHEMBL737640 | 0.74 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130228901-A1 | MATERIALS AND METHODS FOR STRESS REDUCTION IN SEMICONDUCTOR WAFER PASSIVATION LAYERS | DESIGNER MOLECULES, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| US-8138296-B2 | Epoxy compounds and process for their production | SHOWA DENKO K.K. (JP) | 2012-03-20 | — | — | US | disclosed |
| US-7880018-B2 | Epoxy compound and production process of same | SHOWA DENKO K.K. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-20100197936-A1 | NOVEL EPOXY COMPOUND AND PRODUCTION PROCESS OF SAME | SHOWA DENKO K.K. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-20090182110-A1 | NOVEL EPOXY COMPOUNDS AND PROCESS FOR THEIR PRODUCTION | SHOWA DENKO K.K. (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182110-A1 | NOVEL EPOXY COMPOUNDS AND PROCESS FOR THEIR PRODUCTION | ELOVL3, ACSL3, ACSL4 | ALDH1A1 848/4885SMN1; SMN2 4751/4885HTT 3954/4885 |
| US-20100197936-A1 | NOVEL EPOXY COMPOUND AND PRODUCTION PROCESS OF SAME | OXER1, RER1, ORC3 | ALDH1A1 777/4885SMN1; SMN2 2753/4885HTT 4736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.